SuperworthAnaptysbio market cap ANAB
Share price times shares outstanding: what the whole company sells for, since 2017.
- Today, Oct 23, 2026
- $1.5B
- Highest close in our data
- $3B
- Mar 2018
Anaptysbio is worth $1.5B at the close on Oct 23, 2026, at $48.73 a share.
That is up 48% over the last year and up 61% over five years.
Its highest close in our data was $3B in Mar 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.5B | $1.2B | $2.5B | +5% |
| 2025 | $1.4B | $432.2M | $1.4B | +250% |
| 2024 | $396.6M | $396.6M | $1.1B | −30% |
| 2023 | $569.2M | $379.9M | $767.2M | −35% |
| 2022 | $881.1M | $553.9M | $928M | −8% |
| 2021 | $956M | $571M | $1B | +63% |
| 2020 | $587.8M | $361.1M | $804.4M | +29% |
| 2019 | $454.6M | $276.4M | $2.2B | −73% |
| 2018 | $1.7B | $1.5B | $3B | −30% |
| 2017 | $2.4B | $445.4M | $2.4B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Anaptysbio's size, closest first, today.
| Company | Market cap |
|---|---|
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.7B |
| OMEROmeros | $1.2B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ABUSArbutus Biopharma | $831M |
| NRIXNurix Therapeutics | $2.8B |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Anaptysbio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.